Bart, Gavin
Korthuis, P. Todd
Donohue, Julie M.
Hagedorn, Hildi J.
Gustafson, Dave H.
Bazzi, Angela R.
Enns, Eva
McNeely, Jennifer
Ghitza, Udi E.
Magane, Kara M.
Baukol, Paulette
Vena, Ashley
Harris, Jacklyn
Voronca, Delia
Saitz, Richard
Funding for this research was provided by:
National Institute on Drug Abuse (UG1DA040316, UG1DA040316, UG1DA040316, UG1DA040316, UG1DA040316, UG1DA040316, UG1DA040316, UG1DA040316, UG1DA040316, UG1DA040316, Contract No. 75N95020D00012, Contract No. 75N95020D00012, Contract No. 75N95020D00012, UG1DA040316)
Article History
Received: 10 February 2024
Accepted: 20 March 2024
First Online: 11 April 2024
Declarations
:
: The study protocol was approved by Advarra (Protocol number Pro00047868), a commercial Institutional Review Board.
: The authors declare no competing interests.